股票代码：600195 股票简称：中牧股份 编号：临 2026-006 中牧实业股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中牧实业股份有限公司（以下简称"公司"或"中牧股份"）分别于 2025 年 12 月 26 日、2026 年 1 月 12 日召开第九届董事会 2025 年第十五次临时会议、 2026 年第一次临时股东会审议通过《关于续聘天健会计师事务所（特殊普通合 伙）为公司 2025 年度财务审计和内部控制审计机构的议案》，同意公司续聘天健 会计师事务所（特殊普通合伙）执行公司 2025 年度财务审计业务和内部控制审 计业务。具体内容详见公司于 2025 年 12 月 27 日披露的《中牧实业股份有限公 司关于续聘会计师事务所的公告》（公告编号：临 2025-043），于 2026 年 1 月 13 日披露的《中牧实业股份有限公司 2026 年第一次临时股东会决议公告》（公 告编号：临 2026-001）。 公司于近日收到天健会计师事务所（特殊普通合伙）《关于变更签字注 ...

Investment Rating - Industry Rating: Recommended [3] Core Insights - The report highlights the implementation of a national seed market inspection for spring crops, focusing on key crops such as corn, soybeans, rice, cotton, potatoes, and vegetables. This initiative aims to ensure seed quality and combat counterfeit products, which is expected to enhance the planting industry chain [1][11]. - The report anticipates a continued acceleration in the commercialization of genetically modified (GM) seeds, which is crucial for improving self-sufficiency rates in key varieties. The upcoming central document is expected to catalyze the seed industry sector [1][11]. - In the pig farming sector, the average price of live pigs has decreased to 12.61 CNY/kg, reflecting a 2.91% week-on-week decline. This trend is attributed to seasonal consumption patterns and inventory adjustments post-holiday [2][12]. - The report suggests that the pig farming sector may see accelerated capacity reduction as it enters a traditional off-season for pork consumption, presenting potential investment opportunities [2][12]. Summary by Sections Planting Industry Chain - The Ministry of Agriculture and Rural Affairs has initiated a seed market inspection to ensure the safety of seeds for spring production, focusing on major crops [1][11]. - The emphasis on GM technology is expected to revolutionize yield improvements and enhance self-sufficiency in key crops [1][11]. - Recommended stocks in the planting sector include Beidahuang and Suqian Agricultural Development, with a focus on companies with significant first-mover advantages in the seed industry such as Dabeinong and Longping High-Tech [1][11]. Pig Farming - The average price of live pigs is currently 12.61 CNY/kg, with a notable week-on-week decline of 2.91% due to seasonal factors and inventory management [2][12]. - The number of breeding sows has decreased to 39.61 million, reflecting a 2.9% year-on-year decline, indicating a trend towards capacity reduction [2][12]. - Recommended stocks in the pig farming sector include Lihua Agricultural, Muyuan Foods, and Shuanghui Development, among others [2][12]. Key Agricultural Product Data Tracking - Corn: The average price is 2377.26 CNY/ton, with a week-on-week increase of 0.32% [26]. - Wheat: The average price is 2529.67 CNY/ton, with a week-on-week increase of 0.18% [29]. - Soybeans: The average price is 4072.11 CNY/ton, remaining stable week-on-week [41]. - Cotton: The average price is 15750 CNY/ton, with a week-on-week increase of 0.56% [46]. Feed and Vitamin Prices - The average price of pig feed is 2.65 CNY/kg, stable week-on-week [53]. - Vitamin E averages 55.30 CNY/kg, reflecting a week-on-week increase of 1.47% [63].

Core Viewpoint - The animal health sector experienced a slight decline of 0.23% on January 30, with Jinhe Biological leading the drop. The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1]. Group 1: Stock Performance - The closing prices and performance of key stocks in the animal health sector showed varied results, with Huisheng Biological rising by 3.51% to 29.46, while Jinhe Biological fell by 2.98% to 6.51 [1][2]. - The trading volume for Huisheng Biological was 303,100 shares, with a transaction value of 901 million yuan, indicating strong market interest [1]. Group 2: Capital Flow - The animal health sector saw a net inflow of 59.82 million yuan from institutional investors, while retail investors experienced a net outflow of 81.83 million yuan, indicating a shift in investor sentiment [2][3]. - Among individual stocks, Huisheng Biological attracted a significant net inflow of 1.23 billion yuan from institutional investors, while Jinhe Biological faced a net outflow of 543.32 million yuan [3].

证券之星消息，1月29日动物保健板块较上一交易日下跌2.02%，中牧股份领跌。当日上证指数报收于 4157.98，上涨0.16%。深证成指报收于14300.08，下跌0.3%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002141 | 贤丰控股 | 4.03 | 1.26% | 40.64万 | 1.61亿 | | 920970 | 大禹生物 | 8.39 | 0.48% | 2.24万 | 1867.84万 | | 603718 | 海利生物 | 6.59 | 0.00% | - 14.68万 | 9656.61万 | | 920275 | 驱动力 | 9.54 | -0.42% | 1.50万 | 1424.95万 | | 603566 | 普莱柯 | 13.79 | -0.86% | 4.69万 | 6483.19万 | | 002868 | *ST绿康 | 35.10 | -0.88% | 1.32万 | 4625.78万 | | 002688 | 金 ...

Core Viewpoint - The company held its first extraordinary board meeting of 2026, where several key resolutions were passed, including the approval of bank credit limits and related party transactions for the year [1][2][4][6][10]. Group 1: Bank Credit and Financing - The board approved a total bank credit limit of 5.771 billion yuan for 2026, with 1.960 billion yuan allocated to the headquarters and 3.811 billion yuan to subsidiaries [2]. - Additionally, the company and its subsidiaries will apply for project financing credit totaling 1.145 billion yuan, with 740 million yuan for the headquarters and 405 million yuan for subsidiaries [2]. Group 2: Related Party Transactions - The board approved ongoing sales of poultry vaccines and veterinary medicines to Shandong Zhongxin Food Group Co., Ltd., with an estimated transaction amount not exceeding 24 million yuan for 2026 [4][14]. - The company will also continue to purchase production raw materials from Xiamen Jindawei Group Co., Ltd., with an estimated transaction amount not exceeding 31 million yuan for 2026 [6][16]. Group 3: Internal Audit and Salary Budget - The board approved the internal audit plan for 2026 [8][9]. - The board also approved the salary budget for 2025, along with the evaluation report for the total salary for 2024 [10][11]. Group 4: Upcoming Shareholder Meeting - The board agreed to convene the second extraordinary shareholder meeting of 2026 to discuss additional matters requiring shareholder approval [11]. Group 5: Performance Forecast - The company anticipates a net profit attributable to shareholders of 148.59 million to 192.29 million yuan for 2025, representing an increase of 77.70 million to 121.41 million yuan compared to the previous year, which is a year-on-year increase of 109.62% to 171.27% [32][33]. - However, the net profit after deducting non-recurring gains and losses is expected to be between 16.90 million and 23.24 million yuan, a decrease of 38.90 million to 45.24 million yuan compared to the previous year, reflecting a year-on-year decrease of 62.60% to 72.80% [33]. Group 6: Reasons for Performance Increase - The increase in net profit is attributed to gains from investments, including the subscription of convertible bonds issued by Xiamen Jindawei Group and the abandonment of the right of first refusal for shares in Zhongpu Biopharmaceutical Co., Ltd. [37]. - The company has also optimized its marketing structure and product development to enhance operational efficiency [37].

每经头条（nbdtoutiao）——从极寒测试到万套装车！半固态电池今年有望搭载多款新车：各大厂商摩 拳擦掌，动力电池技术迎来迭代年 （记者 曾健辉） 每经AI快讯，中牧股份1月28日晚间发布业绩预告，公司预计2025年度实现归属于上市公司股东的净利 润约1.49亿元~1.92亿元，比上年同期增加7770.37万元~1.21亿元，同比增加109.62%~171.27%。业绩变 动主要原因是，2025年，公司认购厦门金达威集团股份有限公司发行的可转换公司债券，同时放弃中普 生物制药有限公司股权的优先购买权，公允价值变动收益和投资收益同比大幅增加，因此，2025年度归 属于上市公司股东的净利润同比增加。 ...

2025年，公司认购厦门金达威集团股份有限公司发行的可转换公司债券，同时放弃中普生物制药有限公 司股权的优先购买权，公允价值变动收益和投资收益同比大幅增加，因此，2025年度归属于上市公司股 东的净利润同比增加。 智通财经APP讯，中牧股份(600195.SH)发布2025年度业绩预告，预计2025年度实现归属于上市公司股 东的净利润14,858.81万元到19,229.05万元，比上年同期增加7,770.37万元到12,140.61万元，同比增加 109.62%到171.27%。 ...

Core Viewpoint - The animal health sector experienced a slight decline of 0.2% on January 28, with Yongshun Biological leading the drop, while the overall market indices showed minor gains [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4151.24, up by 0.27% [1]. - The Shenzhen Component Index closed at 14342.9, up by 0.09% [1]. - The animal health sector's performance is summarized in a table showing individual stock movements, with notable gainers including Biological Shares and Jinhai Biological, which rose by 1.51% and 1.49% respectively [1]. Group 2: Stock Performance - Yongshun Biological saw a significant decline of 7.49%, closing at 10.13, with a trading volume of 141,500 shares and a turnover of 145 million yuan [2]. - Other notable decliners included Shoufeng Holdings and Haili Biological, which fell by 2.21% and 2.08% respectively [2]. - The trading volume and turnover for various stocks in the animal health sector are detailed, indicating varied investor interest [2]. Group 3: Capital Flow - The animal health sector experienced a net inflow of 18.02 million yuan from institutional investors, while retail investors saw a net inflow of 9.33 million yuan [2]. - However, there was a net outflow of 27.35 million yuan from speculative funds, indicating a mixed sentiment among different investor types [2]. - A detailed table shows the net capital flow for individual stocks, highlighting significant movements in and out of various companies [3].

2025年，公司认购厦门金达威集团股份有限公司发行的可转换公司债券，同时放弃中普生物制药有限公 司股权的优先购买权，公允价值变动收益和投资收益同比大幅增加，因此，2025年度归属于上市公司股 东的净利润同比增加。2025年，公司积极应对多重压力，及时优化营销结构，深挖客户需求，积极开发 新产品、拓展新业务；同时公司也进一步加强对日常运营的统筹管理，努力推进公司整体的降本增效。 目前，公司产品市场占有率仍保持较大韧性和活力，公司生产经营平稳有序。 格隆汇1月28日丨中牧股份(600195.SH)公布，预计2025年度实现归属于上市公司股东的净利润14,858.81 万元到19,229.05万元，同比增加109.62%到171.27%。预计2025年度归属于上市公司股东的扣除非经常 性损益的净利润1,690.01万元到2,323.76万元,同比减少62.60%到72.80%。 ...

2025年，公司认购厦门金达威集团股份有限公司发行的可转换公司债券，同时放弃中普生物制药有限公 司股权的优先购买权，公允价值变动收益和投资收益同比大幅增加，因此，2025年度归属于上市公司股 东的净利润同比增加。2025年，公司积极应对多重压力，及时优化营销结构，深挖客户需求，积极开发 新产品、拓展新业务；同时公司也进一步加强对日常运营的统筹管理，努力推进公司整体的降本增效。 目前，公司产品市场占有率仍保持较大韧性和活力，公司生产经营平稳有序。 格隆汇1月28日丨中牧股份(600195.SH)公布，预计2025年度实现归属于上市公司股东的净利润14,858.81 万元到19,229.05万元，同比增加109.62%到171.27%。预计2025年度归属于上市公司股东的扣除非经常 性损益的净利润1,690.01万元到2,323.76万元,同比减少62.60%到72.80%。 ...